Delivery Order SPE2DB22D3401-SPE2DB25FT3TK

Award Date 5/19/25
Potential Completion Date 6/10/25
Potential Value $6.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BENLYSTA 200 MG/ML SYRINGE, a medication, with a ceiling value of $6,152.80 and a period of performance through May 28, 2025. The contract is not set aside and is a firm-fixed-price delivery order. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Benlysta 200 mg/ml syringes. The contract has a firm fixed price of $6,152.80 and a period of performance ending on June 4, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp, a for-profit organization headquartered in Conshohocken, Pennsylvania, holds a significant $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,790.98, is for the delivery of BENLYSTA 200 MG/ML syringes, a specialty medication used for the treatment of certain medical conditions. The contract has a firm fixed price pricing type and an ultimate completion date of November 6, 2024. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,076.40 firm fixed-price contract is for the supply of BENLYSTA 200 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of April 15, 2025 and was awarded on March 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,152.80, is for the delivery of BENLYSTA 200 MG/ML SYRINGEML, a specialty medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 11, 2025. The contract was awarded on March 21, 2025 and does not have a set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,152.80, is for the delivery of 4568011734 BENLYSTA 200 MG/ML SYRINGEML, a medication used to treat certain autoimmune diseases. The contract is a Firm Fixed Price (FFP) type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product, with a ceiling value of $6,165.34 and a completion date of April 22, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BENLYSTA 200 MG/ML SYRINGE. The contract has a firm fixed price with a ceiling value of $3,076.40 and a period of performance through June 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product. The contract is not set aside and has a ceiling value of $19,951.16. It is a firm fixed-price delivery order contract with a period of performance through May 12, 2025. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of BENLYSTA 200 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has a total ceiling value of $2,790.98 and an ultimate completion date of August 13, 2024. This contract is not set aside for any specific business type. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is the prime contractor delivering this product to support the medical...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB25FT3TK
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BENLYSTA 200 MG/ML SYRINGE, a specialty pharmaceutical product. The contract has a firm fixed price of $6,152.80 and a period of performance ending on June 10, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This prime contract enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/18/25, 9:49 AM